Related Experiment Videos
Liver transplantation therapy for children: Part 2
B W Shaw1, R P Wood, S S Kaufman
1Department of Surgery, University of Nebraska Medical Center, Omaha 68105-1065.
Journal of Pediatric Gastroenterology and Nutrition
|November 1, 1988
Summary
Pediatric end-stage liver disease impacts hundreds of children yearly. Liver transplantation offers a significant survival chance, but challenges like organ shortages and referral delays persist.
Area of Science:
- Pediatric Hepatology
- Organ Transplantation
- Immunology
Background:
- End-stage liver disease (ESLD) affects approximately 300 children annually in the U.S.
- Key causes include biliary atresia, alpha 1-antitrypsin deficiency, Wilson's disease, and neonatal hepatitis.
- Liver transplantation is a critical treatment option for pediatric ESLD.
Purpose of the Study:
- To review the current status and challenges of liver transplantation in children with end-stage liver disease.
- To identify barriers to wider application and suggest areas for future improvement.
Main Methods:
- Review of incidence data for pediatric liver disease.
- Analysis of liver transplantation outcomes and survival rates.
- Identification of current challenges and future research directions.
Main Results:
- Liver transplantation offers a 2-year survival rate of 65-85% for children.
- Advances in immunosuppression have significantly improved outcomes.
- Major barriers include physician referral reluctance, donor organ scarcity, and limited transplant center capacity.
Conclusions:
- Despite improved outcomes, significant barriers hinder wider access to pediatric liver transplantation.
- Future advancements require better immunosuppression, rejection diagnostics, organ preservation, and optimized patient care.